The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of O'neill Vincent since 2020.
This trader's CIK number is 1672718.
At the time of last reporting, O'neill Vincent was the See Remarks of Bioxcel Therapeutics, Inc.. (stock ticker symbol BTAI).
Also see all insider trading activities at Bioxcel Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BTAI | 0 | $0 | 6,179 | $3,839 | 4,334 | $0 |
| 2023 | BTAI | 0 | $0 | 30,558 | $908,032 | 33,360 | $12,182 |
| 2021 | BTAI | 0 | $0 | 50,000 | $2,647,600 | 50,000 | $152,875 |
| 2020 | BTAI | 0 | $0 | 25,000 | $1,304,625 | 25,000 | $10,250 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2024-12-16 | BTAI | Sale | 165 | .35 | 58 |
| 2024-10-03 | BTAI | Sale | 5,556 | .55 | 3,055 |
| 2024-09-16 | BTAI | Sale | 138 | .69 | 95 |
| 2024-09-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2024-06-17 | BTAI | Sale | 155 | 1.28 | 199 |
| 2024-06-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2024-03-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2024-03-15 | BTAI | Option Ex | 2,250 | .00 | 0 |
| 2024-04-04 | BTAI | Sale | 165 | 2.62 | 432 |
| 2023-12-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2023-09-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2023-06-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2023-03-14 | BTAI | Option Ex | 2,084 | .00 | 0 |
| 2023-03-15 | BTAI | Sale | 845 | 19.70 | 16,642 |
| 2023-01-20 | BTAI | Option Ex | 29,713 | .41 | 12,182 |
| 2023-01-20 | BTAI | Sale | 29,713 | 30.00 | 891,390 |
| 2021-02-17 | BTAI | Sale | 25,000 | 55.51 | 1,387,700 |
| 2021-02-17 | BTAI | Option Ex | 25,000 | 5.71 | 142,625 |
| 2021-01-19 | BTAI | Sale | 25,000 | 50.40 | 1,259,900 |
| 2021-01-19 | BTAI | Option Ex | 25,000 | .41 | 10,250 |
| 2020-12-28 | BTAI | Option Ex | 25,000 | .41 | 10,250 |
| 2020-12-28 | BTAI | Sale | 25,000 | 52.19 | 1,304,625 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'neill Vincent (See Remarks of Bioxcel Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.